Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor.
Howard I. Scher
Research Funding - Medivation
Other Remuneration - Medivation
Karim Fizazi
Consultant or Advisory Role - Astellas Pharma; Medivation
Honoraria - Astellas Pharma; Medivation
Fred Saad
Consultant or Advisory Role - Astellas Pharma; Medivation
Kim N. Chi
Consultant or Advisory Role - Astellas Pharma
Mary-Ellen Taplin
Consultant or Advisory Role - Medivation
Cora N. Sternberg
Honoraria - Astellas Pharma
Andrew J. Armstrong
Consultant or Advisory Role - Medivation (U)
Research Funding - Medivation
Mohammad Hirmand
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
David Forer
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
Johann Sebastian De Bono
Consultant or Advisory Role - Astellas Pharma
Honoraria - Medivation